Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Turok

Showing results (181-190 of 231) with videos related to

Pageof 24
Sort By:
Women'S Health Issues : Official Publication of the Jacobs Institute of Women'S Health|January 30, 2017
State-Mandated (Mis)Information and Women's Endorsement of Common Abortion MythsNancy F Berglas, Heather Gould, David K Turok, et al.
Maternal and Child Health Journal|July 3, 2013
Prevention of recurrent preterm birth: role of the neonatal follow-up programErin A S Clark, Sean Esplin, Leah Torres, et al.
Women'S Health Issues : Official Publication of the Jacobs Institute of Women'S Health|August 23, 2018
The Impact of Sexual Satisfaction, Functioning, and Perceived Contraceptive Effects on Sex Life on IUD and Implant Continuation at 1 YearJessica N Sanders, Jenny A Higgins, Daniel E Adkins, et al.
Contraception|December 18, 2022
Single dose letrozole and misoprostol for termination of pregnancy through 63 days' gestation: A pilot studyTara Shochet, David Turok, Laura J Frye, et al.
Contraception|May 3, 2015
Three-year efficacy and safety of a new 52-mg levonorgestrel-releasing intrauterine systemDavid L Eisenberg, Courtney A Schreiber, David K Turok, et al.
Contraception|June 10, 2017
One-year continuation of copper or levonorgestrel intrauterine devices initiated at the time of emergency contraceptionJ N Sanders, D K Turok, P A Royer, et al.
Obstetrics and Gynecology|March 14, 2020
Efficacy, Safety, and Tolerability of a New Low-Dose Copper and Nitinol Intrauterine Device: Phase 2 Data to 36 MonthsDavid K Turok, Anita L Nelson, Clint Dart, et al.
BMC Women'S Health|January 22, 2021
Comparison of levonorgestrel level and creamatocrit in milk following immediate versus delayed postpartum placement of the levonorgestrel IUDNiaree G Hopelian, Rebecca G Simmons, Jessica N Sanders, et al.
The Journal of Sexual Medicine|January 17, 2022
Measuring the Sexual Acceptability of Contraception: Psychometric Examination and Development of a Valid and Reliable Prospective InstrumentJessica N Sanders, Jacob Kean, Chong Zhang, et al.
AEM Education and Training|December 23, 2022
Mifepristone for miscarriage treatment in Utah: A survey of clinician knowledge and assessment of an educational video on future useJennifer E Kaiser, Theresa Kurtz, Annabah Glasser, et al.
Pageof 24

Showing results (181-190 of 231) with videos related to

Sort By:
Pageof 24
Women'S Health Issues : Official Publication of the Jacobs Institute of Women'S Health|January 30, 2017
State-Mandated (Mis)Information and Women's Endorsement of Common Abortion MythsNancy F Berglas, Heather Gould, David K Turok, et al.
Maternal and Child Health Journal|July 3, 2013
Prevention of recurrent preterm birth: role of the neonatal follow-up programErin A S Clark, Sean Esplin, Leah Torres, et al.
Women'S Health Issues : Official Publication of the Jacobs Institute of Women'S Health|August 23, 2018
The Impact of Sexual Satisfaction, Functioning, and Perceived Contraceptive Effects on Sex Life on IUD and Implant Continuation at 1 YearJessica N Sanders, Jenny A Higgins, Daniel E Adkins, et al.
Contraception|December 18, 2022
Single dose letrozole and misoprostol for termination of pregnancy through 63 days' gestation: A pilot studyTara Shochet, David Turok, Laura J Frye, et al.
Contraception|May 3, 2015
Three-year efficacy and safety of a new 52-mg levonorgestrel-releasing intrauterine systemDavid L Eisenberg, Courtney A Schreiber, David K Turok, et al.
Contraception|June 10, 2017
One-year continuation of copper or levonorgestrel intrauterine devices initiated at the time of emergency contraceptionJ N Sanders, D K Turok, P A Royer, et al.
Obstetrics and Gynecology|March 14, 2020
Efficacy, Safety, and Tolerability of a New Low-Dose Copper and Nitinol Intrauterine Device: Phase 2 Data to 36 MonthsDavid K Turok, Anita L Nelson, Clint Dart, et al.
BMC Women'S Health|January 22, 2021
Comparison of levonorgestrel level and creamatocrit in milk following immediate versus delayed postpartum placement of the levonorgestrel IUDNiaree G Hopelian, Rebecca G Simmons, Jessica N Sanders, et al.
The Journal of Sexual Medicine|January 17, 2022
Measuring the Sexual Acceptability of Contraception: Psychometric Examination and Development of a Valid and Reliable Prospective InstrumentJessica N Sanders, Jacob Kean, Chong Zhang, et al.
AEM Education and Training|December 23, 2022
Mifepristone for miscarriage treatment in Utah: A survey of clinician knowledge and assessment of an educational video on future useJennifer E Kaiser, Theresa Kurtz, Annabah Glasser, et al.
Pageof 24